Cerulean Pharma Inc. (NASDAQ:CERU) registered a 3.46% increase, still its new closing price is 32.95% up from the company’s 1 year high of 4.33.It posted 6.35% gains in previous 5 sessions and is now the subject of 2 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 1 buy or better ratings. The 3 stock analysts following this company have an average price target at $5.50, with individual PT in the $1.50-$9.00 range. The shares moved at $0.84, implying that brokerage firms see shares losing about -63.57% in twelve months time.

Cerulean Pharma Inc. (CERU) SEC Form 4 News

The stock is getting much attention these days as insiders are adding shares while they posted a 18.33% rise year to date. A Director at Cerulean Pharma Inc. (CERU) acquired shares in a transaction closed on Monday February 22, 2016. WALT DAVID R bought 2,291 shares in the company at $2.08 each and collected $4,001 in proceeds. WALT DAVID R now owns 167,491 shares in the company after this transaction. A Director in the company, WALT DAVID R, disclosed a transaction on Thursday February 18, 2016 that ended up paying $18,001 from the purchase of 8,960 shares at $2.1 per share.

Cerulean Pharma Inc. (NASDAQ:CERU) Upcoming Results on Tap

Cerulean Pharma Inc. will next provide financial results for the December 2017 quarter. Stock analysts expect it to report per-share earnings of $1.10 in that period. Sales during the quarter are predicted to arrive at $0.

Cerulean Pharma Inc. (CERU) Brokerage Update 

Cerulean Pharma Inc. (CERU) is in Leerink Partners’s research list so their analyst rating change is noteworthy. These shares were downgraded to Mkt Perform from Outperform by Leerink Partners, according to news reported on Thursday August 18, 2016.Another important research note was issued by JMP Securities on Thursday August 18, 2016.The firm downgraded CERU to Mkt Perform from Mkt Outperform. Over the last six months and over the last three months, the shares of Cerulean Pharma Inc. (CERU), have changed -70.28% and 5.09%, respectively.